… vaccines that offer more effective and broad-spectrum protection. Here, we report a circular
RNA (circRNA) vaccine … , providing robust protection against SARS-CoV-2 in both mice and …

… -19 pandemic caused by the SARS-CoV-2 virus that emerged in 2019 has highlighted the
potential of RNA vaccines. These vaccines possess several advantages, such as high efficacy…

… , a vaccine is urgently needed. Here I review the development of vaccines against SARS-CoV-2. …
RNA vaccines have shown great promise in recent years and many of them are in …

… of an RNA-based delivery mechanism promises fast vaccine … RNA vaccines are safe in
theory and have shown acceptable … Immunogenicity of SARS-CoV-2 mRNA vaccines in phase 1 …

… We examined antibody response after the first and second doses of vaccines in the subset
of patients with prior SARS-CoV-2 infection who were excluded from the overall vaccine …

… are at high risk of COVID-19 following SARS-CoV-2 infection; however, their ability to
produce an adequate antibody response to messenger RNA SARS-CoV-2 vaccines is unclear. …

… RBD of the spike protein of SARS-CoV-2, a key target of virus-… The vaccine RNA is formulated
in lipid nanoparticles for more… of several RNA-based SARS-CoV-2 vaccine candidates 18 …

… Society of Transplantation, anti–SARS-CoV-2 spike protein antibodies were monitored
before and after vaccination. We used the SARS-CoV-2 total antibodies enzyme-linked …

… studies of SARS-CoV-2 S–targeted DNA and live viral vector vaccines tested in nonhuman
primates (53, 58). In addition, the ability of our repRNA vaccine to induce anti–SARS-CoV-2 S…

… vaccines that can protect against multiple VoC. In this report, we evaluated an alphavirus- …
replicating RNA vaccine expressing Spike proteins from the original SARS- CoV- 2 Alpha …